TLSI Q4 2023 Earnings — TriSalus Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

TLSITriSalus Life Sciences, Inc.

$175M

Q4 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$6M+77.3% YoY

Gross Profit

$5M89.8% margin

Operating Income

-$14M-246.8% margin

Net Income

-$36M-620.7% margin

EPS (Diluted)

$-1.34

QoQ Revenue Growth

+10.2%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$10M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$25M

Total Liabilities

$52M

Stockholders' Equity

-$27M

Cash & Equivalents

$12M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$3M	+77.3%
Gross Profit	$5M	$2M	+113.2%
Operating Income	-$14M	-$12M	-19.9%
Net Income	-$36M	-$23M	-57.5%